Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study

Figure 1

Efficacy of NDLS-based chemotherapy for the treatment of sarcoma in metastatic setting (n = 6). CR: complete response; DCR: disease control rate; NDLS: nanosomal docetaxel lipid suspension; ORR: overall response rate; PR: partial response. Disease progression was reported in 2 patients.